Regulatory innovation for health products: Agile licensing for drugs

Description

The Canadian market now includes a much larger number of drugs that reflect a wider range of risks. Our drug regulatory system needs to be more agile to give people better access to the drugs they need.

Resources

Name Format Description Link
Regulatory innovation for health products: Agile licensing for drugs HTML https://www.canada.ca/en/health-canada/corporate/about-health-canada/activities-responsibilities/strategies-initiatives/health-products-food-regulatory-modernization/agile-licensing-drugs.html
Regulatory innovation for health products: Agile licensing for drugs HTML https://www.canada.ca/fr/sante-canada/organisation/a-propos-sante-canada/activites-responsabilites/strategies-initiatives/modernisation-reglementation-aliments-produits-sante/licence-agile-medicaments.html

Tags

Topics

Categories